THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise
THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise
THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The Company’s Performance in 2008 – A Comparison between<br />
the Actual and Forecast Course of Business<br />
The forecast delivered on March 5, 2008 at the presentation of<br />
the 2007 business results was for organic, currency-adjusted sales<br />
growth of 5% to 6% (excluding acquisitions) and an increase in the<br />
EBITDA margin to 22% for fiscal 2008, the year having got off to a<br />
good start.<br />
However, in mid-2008 we had to revise our sales growth and<br />
EBITDA margin forecasts downwards. The main reasons for this<br />
were the rapidly weakening business environment, an unforeseeably<br />
high increase in raw materials prices and energy costs, and<br />
the slight margin dilution due to the acquisition of Chr. Hansen<br />
Flavors. The adjusted forecast issued at the end of July predicted<br />
sales growth at local currency (including acquisitions) of 6% to 7%,<br />
and an EBITDA margin of approximately 21%.<br />
In the course of the third quarter, the economic situation worsened<br />
further. At the same time, our negotiations with customers on<br />
price increases lasted longer than anticipated. In addition, our customers<br />
grew increasingly cautious over ordering their materials,<br />
making our business more difficult to plan and predict. In the end,<br />
we had to adjust our earnings forecast once again. At the end of<br />
October we announced an EBITDA margin of approximately 20%.<br />
We were able to maintain our sales growth forecast (currencyadjusted),<br />
including acquisitions, of 6% - 7%.<br />
Raw materials prices rose relentlessly until the end of November<br />
2008, with price increases first starting to slow in the course of<br />
December. In the fourth quarter, moreover, customers transferred<br />
orders from 2008 to 2009 to minimize working capital. The positive<br />
effects of our price increases only became evident in the<br />
fourth quarter and failed to offset the significantly higher cost of<br />
sales. Against this backdrop, we failed to meet our target of achieving<br />
currency-adjusted EBITA on a par with the previous year. At<br />
current rates EBITA fell by 5%. The EBITDA margin reached 19.9%,<br />
within our target range of around 20%.<br />
ACHIEVEMENT <strong>OF</strong> GOALS<br />
Sales growth (in local currencies)<br />
EBITDA margin<br />
EBITA<br />
Adjusted EPS<br />
Free Cash Flow<br />
The fact that we did not meet our EBITA target had a negative impact<br />
on adjusted earnings per share (EPS). We were not able to increase<br />
adjusted EPS as forecast; instead they remained at the<br />
previous year’s level of € 1.02. However, we see this as an indication<br />
of the robustness of our business amid the steadily worsening<br />
business environment in 2008.<br />
4. RESULTS <strong>OF</strong> OPERATIONS<br />
Sales<br />
<strong>Symrise</strong> achieved total sales of € 1,319.9 million in 2008. On a<br />
local currency basis, this represents an increase of 6.5%. Based on<br />
actual rates, sales rose by € 45.4 million (3.6%) compared to 2007.<br />
Sales excluding the acquisitions discussed above climbed in local<br />
currencies by 3.5% (0.8% at actual rates).<br />
The sales performance of Scent & Care in fiscal 2008 was mixed.<br />
While Life Essentials, Household, Aroma Molecules and Mint performed<br />
according to plan, the “luxury segments” Fine Fragrances<br />
and Personal Care had to contend with demand problems caused<br />
by the global economic situation. In 2008, Scent & Care generated<br />
sales of € 671.8 million. As a result, including the acquisitions<br />
Intercontinental Fragrances and Manheimer Fragrances,<br />
sales reached the previous year’s mark. At local exchange rates<br />
Scent & Care’s sales were up by 3%. Excluding Intercontinental<br />
Fragrances and Manheimer Fragrances, sales fell slightly by 0.7%<br />
to € 666.8 million (+ 2.2% on a local currency basis).<br />
Including Chr. Hansen Flavors, Flavor & Nutrition recorded sales of<br />
€ 648.1 million in 2008, an increase of 7.4% (10.4% at local rates).<br />
Excluding Chr. Hansen Flavors, sales rose by 2.4% to € 617.5 million<br />
(5.0% on a local currency basis). After the acquisition in April,<br />
Chr. Hansen flavors posted sales of € 30.6 million.<br />
In fiscal 2008, sales in the emerging countries rose 8% (on a local<br />
currency basis) compared to the previous year, thus contributing<br />
to the overall sales growth.<br />
Goal in 2008 (as of October 28, 2008)<br />
6% - 7% (incl. acquisitions)<br />
Approximately 20%<br />
EBITA at previous year’s level in LC<br />
Currency-adjusted growth of 4% - 6%<br />
9% -10% of Sales<br />
Achievement of goals in 2008<br />
6.5%<br />
19.9%<br />
- 5%<br />
0%<br />
9.3%<br />
68 Annual Report 2008 <strong>Symrise</strong> AG